Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001520138-21-000537
Filing Date
2021-09-14
Accepted
2021-09-13 21:14:43
Documents
4
Period of Report
2021-09-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A bivi-def14a.htm DEF 14A 290083
2 GRAPHIC image_001.jpg GRAPHIC 2493
3 GRAPHIC image_005.jpg GRAPHIC 97058
4 GRAPHIC image_006.jpg GRAPHIC 69136
  Complete submission text file 0001520138-21-000537.txt   523858
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39015 | Film No.: 211251052
SIC: 2834 Pharmaceutical Preparations